BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 117925
Published online Jun 27, 2026. doi: 10.4240/wjgs.117925
Table 3 Comparison of postoperative data, n (%)/median (interquartile rage)

Routine care group (n = 146)
Comprehensive care group (n = 131)
P value
Postoperative immunosuppressive induction
Basiliximab145 (99.32)128 (97.71)0.539
Immunosuppressive maintenance
Cyclosporine A4 (2.74)4 (3.05)1.000
Glucocorticoid124 (84.93)103 (78.63)0.173
Tacrolimus FK506139 (95.21)125 (95.42)0.993
Mycophenolate mofetil37 (25.34)101 (77.10)< 0.001
Postoperative leukopenia30 (20.55)24 (18.32)0.640
Postoperative mechanical ventilation time (hours)17 (12-60.5)16 (13-26.5)0.634
ICU stay (days)7.9 (5.6-13.5)7.0 (4.8-11.5)0.481
OAG score
Day 15 (5-6)5 (5-6)0.958
Day 26 (5-7)6 (6-6)0.202
Day 36 (6-7)6 (6-7)0.008
Day 47 (7-8)7 (7-7)0.012
Day 58 (8-9); n = 1427 (7-7); n = 117< 0.001
Day 69 (9-10); n = 1217 (7-7); n = 98< 0.001
Day 79 (9-10); n = 967 (7-7); n = 74< 0.001
Day 89 (9-10); n = 837 (7-7); n = 66< 0.001
Day 99 (9-10); n = 657 (7-7); n = 58< 0.001
Day 109 (9-10); n = 537 (7-7); n = 50< 0.001
Day 119 (9-10); n = 477 (7-7); n = 42< 0.001
Day 129 (9-10); n = 407 (7-7); n = 35< 0.001
Oral complications20 (13.70)7 (5.34)0.019
Survival rate at ICU discharge98.63%99.23%1.000


Write to the Help Desk